Effect of G-CSF Administration on the Appearance of Splenic Colonies in Hybrid Resistance
Recipient . | Treatment* . | Donor . | BM Cells† . | Day-8 Splenic Colony‡ . |
---|---|---|---|---|
B6D2F1 | (−) | B6 | 1 × 105 | 0.7 ± 1.2 |
2.5 × 105 | 0.7 ± 1.1 | |||
1 × 106 | 2.3 ± 1.5 | |||
B6D2F1 | G-CSF | B6 | 1 × 105 | 3.0 ± 2.0 |
2.5 × 105 | 10.0 ± 3.9 | |||
1 × 106 | 25.3 ± 1.5 | |||
B6D2F1 | AGM1 | B6 | 1 × 105 | 11.3 ± 3.5 |
2.5 × 105 | 21.0 ± 3.1 | |||
B6 | (−) | B6 | 1 × 105 | 18.0 ± 1.7 |
G-CSF | 1 × 105 | 19.0 ± 5.7 |
Recipient . | Treatment* . | Donor . | BM Cells† . | Day-8 Splenic Colony‡ . |
---|---|---|---|---|
B6D2F1 | (−) | B6 | 1 × 105 | 0.7 ± 1.2 |
2.5 × 105 | 0.7 ± 1.1 | |||
1 × 106 | 2.3 ± 1.5 | |||
B6D2F1 | G-CSF | B6 | 1 × 105 | 3.0 ± 2.0 |
2.5 × 105 | 10.0 ± 3.9 | |||
1 × 106 | 25.3 ± 1.5 | |||
B6D2F1 | AGM1 | B6 | 1 × 105 | 11.3 ± 3.5 |
2.5 × 105 | 21.0 ± 3.1 | |||
B6 | (−) | B6 | 1 × 105 | 18.0 ± 1.7 |
G-CSF | 1 × 105 | 19.0 ± 5.7 |